Medifast, Inc. (MDF.F)
| Previous close | 30.47 |
| Open | 31.27 |
| Bid | 31.07 x 10700 |
| Ask | 31.82 x 10300 |
| Day's range | 31.27 - 31.27 |
| 52-week range | 29.07 - 98.00 |
| Volume | |
| Avg. volume | 13 |
| Market cap | 350.111M |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | 3.68 |
| EPS (TTM) | 8.50 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | 6.16 (20.21%) |
| Ex-dividend date | 18 Sept 2023 |
| 1y target est | 363.33 |
ZacksMedifast's (MED) Transformation on Track Amid Macro Headwinds
Medifast (MED) adapts to shifting consumer behavior to maintain its relevance. However, it is facing difficulties in attracting customers due to the rapidly changing economy and inflation.
Insider MonkeyHere’s Why Miller Income Strategy Sold Medifast (MED)
Miller Value Partners, an investment management company, released its “Income Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the first quarter, the strategy returned 11.69% net of fees versus a 1.52% return for the benchmark, ICE BofA US High Yield Index. In addition, please check the fund’s top […]
Business WireMedifast to Announce Financial Results for the First Quarter Ended March 31, 2024
BALTIMORE, April 15, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
